| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 527E7SK68P |
| InChI Key | FYSRKRZDBHOFAY-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C19H12F4N4O2 |
| Molecular Weight | 404.32 |
| AlogP | 3.62 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 102.31 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 29.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | MAP kinase p38 alpha inhibitor |
| Primary Target | |
|---|---|
| mitogen-activated protein kinase 11 | |
| mitogen-activated protein kinase 14 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 94489 |
| ChEMBL | CHEMBL1090090 |
| DrugBank | DB05470 |
| FDA SRS | 527E7SK68P |
| Guide to Pharmacology | 6059 |
| PubChem | 10341154 |
| SureChEMBL | SCHEMBL185712 |
| ZINC | ZINC000036377992 |